Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al > Summary
Court Case Number 1:22-cv-00451
Filing Date Apr 5, 2022
Court Delaware District Court
Status Unknown
JudgesRichard G. Andrews
Plaintiff
Plaintiff Attorneys
13Novartis
Attorney Name: Sandra K. Law
Schrader Companion Duff & Law, PLLC
Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Christina A. Schwarz
Venable
Novartis
Attorney Name: Christopher E. Loh
Venable
Novartis
Attorney Name: Jared L. Stringham
Venable
Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Melinda R. Roberts
Venable
Novartis
Attorney Name: Adel Remond Rizkala
Novartis
Novartis
Attorney Name: Nicole Twisk
Novartis
Novartis
Attorney Name: Fabian Chen
Novartis
Novartis
Attorney Name: Michael Motto
Novartis
Novartis
Attorney Name: Peter J. Waibel
Venable
Defendant Attorneys
5Viatris Inc.
Attorney Name: Robert L. Florence
Parker Poe Adams & Bernstein LLP
Viatris Inc.
Attorney Name: David E. Moore
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: Gordon H. Copland
Steptoe & Johnson PLLC
Viatris Inc.
Attorney Name: Melanie B. Dubis
Parker Poe Adams & Bernstein LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11058667 | Sacubitril-valsartan dosage regimen for treating heart failure | Jul 13, 2021 |
